Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Stay on the cutting edge of major market events in drug development. Powered by real-time intelligence, Biomedtracker’s web-based platform tracks and analyzes clinical and regulatory developments so you can quickly and accurately assess a drug's probability of technical success.
How it helps
Biomedtracker's exclusive likelihood of approval analyses highlight the "bottom line" impact of today’s news on your business. Our expert industry analysts draw insights from closely monitoring companies, clinical trials, deals, and regulatory meetings to capture and report on the most critical events.
How it works
Biomedtracker’s intuitive interface features the latest, industry-acclaimed insights, all at your fingertips. We track impactful future catalysts, and then analyze these commercial, clinical, and regulatory activities as they happen, and present them to you via an easily searchable interface that keeps you at the top of your game.
Our analysts attend the medical and investor meetings that matter to you, bringing you not just the news, but vital information on how it impacts your bottom line.
Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet...
Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.
Topic Coronavirus
Biomedtracker
In this infographic, we provide insight into key trials that are expecting developments in the approval process.
Biomedtracker, Datamonitor Healthcare
Anticipate the biggest, most impactful expected catalysts of early 2020 with the guidance and insights from Pharma Intelligence. Building off Biomedtracker’s Early 2020 Outlook report, our live webinar will include market context for these upcoming milestones and additional insights from Datamonitor Healthcare’s Therapeutic Area Directors.
Topic FDA
Biomedtracker, Meddevicetracker
The 38th Annual J.P. Morgan Healthcare Conference has concluded, and Biomedtracker and Meddevicetracker were there to bring you the important outcomes from the largest and most informative annual healthcare investment symposium in the industry.
Biomedtracker, Datamonitor Healthcare
Access vital post-ASH meeting reporting from the expert analysts at Datamonitor Healthcare and Biomedtracker.
Biomedtracker, Datamonitor Healthcare
Tap into insights and highlights from ESMO’s annual meeting of oncology clinicians, researchers, patient advocates, journalists, and members of the pharmaceutical industry.
Biomedtracker
Biomedtracker boils down all the important mergers and acquisitions activities in Q1.
Biomedtracker, Meddevicetracker
What major drug catalysts and events can you expect to see this quarter? Get a view of what's to come with an extract from the full report.
Biomedtracker
What were the outcomes of critical catalysts featured in Biomedtracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free.
Topic Drug approval Drug review FDA
Biomedtracker, Datamonitor Healthcare
Take a longer-term look at key late-stage drugs projected to hit the market in 2020, including new drug classes, major changes to standards of care, and/or large market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.
Biomedtracker
Discover how creating custom company portfolios can help you overcome your toughest business challenges.
Topic Business strategies
Biomedtracker
In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.
Topic Drug development landscape Drug review Research Strategy
Datamonitor Healthcare, Biomedtracker, Pharmapremia
Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.
Meddevicetracker, Biomedtracker
Staying on top of what’s going in the competitive Medtech market and getting a complete view of the competitive landscape and current market trends is critical to your business. Often, this essential information is fragmented and difficult to find, and gathering and synthesizing it is tedious and time consuming. Now, Biomedtracker puts this critical information at your fingertips, saving you time and effort. The new “Associated Products” section on relevant Biomedtracker Drug Profile pages shows you the full competitive landscape – including drugs, devices, and diagnostics – with a single search.
Topic Business strategies Medtech
Datamonitor Healthcare, Biomedtracker
Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.
USA
Rachel specializes in
+24 year(s) experience
San Diego, USA
Gail specializes in
+23 year(s) experience
Support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. Datamonitor Healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. Our primary research with physicians, payers, and KOLs (key opinion leaders) informs our treatment standards data and patient-based forecasts.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
From discovery to patent expiry, and coverage spanning both ethical and generic drugs, Medtrack has you covered. Stay current on key financing, drug and biologics development and drug manufacturing information, all with a single tool.
Looking for more products Product Finder
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
